China & Pfizer
10 shared events · Importance 3 · Last updated Aug 24, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
Ergen Dashboard
Regulatory
China: Chinese biotech companies stand to benefit from continued US investment and licensing deals, though the rules remain under negotiation.
Pfizer: Pfizer has lobbied against broad restrictions and announced an up to $10.5 billion collaboration with Innovent Biologics covering 12 oncology programs.
Sep 18, 2026 · 6 articles
Business
China: China's obesity epidemic and regulatory environment shape the market. The government projects rising obesity rates and restricts direct drug advertising.
Pfizer: Pfizer entered the Chinese market with Xianweiying and partners with gyms for promotions. It is a newer entrant seeking market share.
Aug 24, 2026 · 6 articles
Domestic
China: Lab leak theory discussion may affect China's international reputation.
Pfizer: Mentioned as vaccine manufacturer; no direct impact from diary release.
Jul 29, 2026 · 13 articles
Business
China: AI startups surged on domestic chip developments. Potential U.S. import ban on components.
Pfizer: Reported upbeat quarterly results, leading to a stock gain.
Jul 14, 2026 · 280 articles
International
China: Accounts for 15% of computing power among top 500 AI supercomputers, according to the scientific panel report.
Pfizer: CEO Albert Bourla joined the AI for Good Global Commission.
Apr 20, 2026 · 123 articles
Business
China: Inclusion of Mounjaro in its National Reimbursement Drug List compressed international pricing, one of the factors behind Lilly's recent share decline.
Pfizer: Peer with only about 4.1% implied upside and Hold-skewed ratings, underscoring how Lilly stands out on analyst-implied returns within pharma.
Sep 14, 2026 · 6 articles
Accidents
China: China is noted as the country where the vast majority of hantavirus cases occur annually, providing context on the global prevalence of the virus.
Pfizer: Pfizer is mentioned in false conspiracy theories linking its vaccine to the Hantavirus outbreak, which health officials are working to counter.
May 07, 2026 · 368 articles
Business
China: Ascentage Pharma operates in China and has approvals from Chinese regulators, but this event does not directly impact the country.
Pfizer: Pfizer is a partner of Ascentage Pharma, but this event does not directly involve Pfizer.
Jul 26, 2026 · 6 articles
ERGEN INTELLIGENCE
Explore this relationship live
Track how China and Pfizer interact across events, view sentiment trends, and discover connected entities.
Open Dashboard